1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Craig WJ: Health-promoting properties of
common herbs. The Am J Clin Nutr. 70:491S–499S. 1999.PubMed/NCBI
|
3
|
Sun Y, Xun K, Wang Y and Chen X: A
systematic review of the anticancer properties of berberine, a
natural product from Chinese herbs. Anticancer Drugs. 20:757–769.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Liu Z, Liu Q, Xu B, et al: Berberine
induces p53-dependent cell cycle arrest and apoptosis of human
osteosarcoma cells by inflicting DNA damage. Mutat Res. 662:75–83.
2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine inhibits growth, induces G1 arrest and apoptosis in human
epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin
cascade, disruption of mitochondrial membrane potential and
cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006.
View Article : Google Scholar
|
6
|
Katiyar SK, Meeran SM, Katiyar N and
Akhtar S: p53 Cooperates berberine-induced growth inhibition and
apoptosis of non-small cell human lung cancer cells in vitro and
tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Letasiová S, Jantová S, Cipák L and
Múcková M: Berberine-antiproliferative activity in vitro and
induction of apoptosis/necrosis of the U937 and B16 cells. Cancer
Lett. 239:254–262. 2006.PubMed/NCBI
|
8
|
Meeran S and Katiyar S and Katiyar S:
Berberine-induced apoptosis in human prostate cancer cells is
initiated by reactive oxygen species generation. Toxicol Appl
Pharmacol. 229:33–43. 2008. View Article : Google Scholar
|
9
|
Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu
CY: Berberine induces apoptosis through a mitochondria/caspases
pathway in human hepatoma cells. Arch Toxicol. 80:62–73. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Anis KV, Rajeshkumar NV and Kuttan R:
Inhibition of chemical carcinogenesis by berberine in rats and
mice. J Pharm Pharmacol. 53:763–768. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nishino H, Kitagawa K, Fujiki H and
Iwashima A: Berberine sulfate inhibits tumor-promoting activity of
teleocidin in two-stage carcinogenesis on mouse skin. Oncology.
43:131–134. 1986. View Article : Google Scholar : PubMed/NCBI
|
12
|
Peng PL, Hsieh YS, Wang CJ, Hsu JL and
Chou FP: Inhibitory effect of berberine on the invasion of human
lung cancer cells via decreased productions of
urokinase-plasminogen activator and matrix metalloproteinase-2.
Toxicol Appl Pharmacol. 214:8–15. 2006. View Article : Google Scholar
|
13
|
Kim S, Choi JH, Kim JB, et al: Berberine
suppresses TNF-alpha-induced MMP-9 and cell invasion through
inhibition of AP-1 activity in MDA-MB-231 human breast cancer
cells. Molecules. 13:2975–2985. 2008. View Article : Google Scholar
|
14
|
Parry MC, Bhabra G, Sood A, et al:
Thresholds for indirect DNA damage across cellular barriers for
orthopaedic biomaterials. Biomaterials. 31:4477–4483. 2010.
View Article : Google Scholar
|
15
|
Sokolov MV, Smilenov LB, Hall EJ, Panyutin
IG, Bonner WM and Sedelnikova OA: Ionizing radiation induces DNA
double-strand breaks in bystander primary human fibroblasts.
Oncogene. 24:7257–7265. 2005. View Article : Google Scholar
|
16
|
Liu J, Yang F, Zhang Y and Li J: Studies
on the cell-immunosuppressive mechanism of Oridonin from Isodon
serra. Int Immunopharmacol. 7:945–954. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhao YY, Shen X, Chao X, et al:
Ergosta-4,6,8(14), 22-tetraen-3-one induces G2/M cell cycle arrest
and apoptosis in human hepatocellular carcinoma HepG2 cells.
Biochim Biophys Acta. 1810.384–390. 2011.PubMed/NCBI
|
18
|
Guanggang X, Diqiu L, Jianzhong Y, et al:
Carbamate insecticide methomyl confers cytotoxicity through DNA
damage induction. Food Chem Toxicol. 53:352–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Scott EN, Gescher AJ, Steward WP and Brown
K: Development of dietary phytochemical chemopreventive agents:
biomarkers and choice of dose for early clinical trials. Cancer
Prev Res (Phila). 2:525–530. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Letasiová S, Jantová S, Miko M, Ovádeková
R and Horváthová M: Effect of berberine on proliferation,
biosynthesis of macromolecules, cell cycle and induction of
intercalation with DNA, dsDNA damage and apoptosis in Ehrlich
ascites carcinoma cells. J Pharm Pharmacol. 58:263–270.
2006.PubMed/NCBI
|
21
|
Patil JB, Kim J and Jayaprakasha GK:
Berberine induces apoptosis in breast cancer cells (MCF-7) through
mitochondria-dependent pathway. Eur J Pharmacol. 645:70–78. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang RX, Dougherty DV and Rosenblum ML:
Laboratory studies of berberine used alone and in combination with
1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain
tumors. Chin Med J (Engl). 103:658–665. 1990.
|
23
|
Pasqual MS, Lauer CP, Moyna P and
Henriques JA: Genotoxicity of the isoquinoline alkaloid berberine
in prokaryotic and eukaryotic organisms. Mutat Res. 286:243–252.
1993. View Article : Google Scholar : PubMed/NCBI
|
24
|
Cheng CC, Engle RR, Hodgson JR, et al:
Absence of mutagenicity of coralyne and related antileukemic
agents: structural comparison with the potent carcinogen
7,12-dimethylbenz[a]anthracene. J Pharm Sci. 66:1781–1783.
1977.PubMed/NCBI
|